Szapary PO - Search Results

1

Antidiabetic action of bezafibrate in a large observational database.

Flory JH, Ellenberg S, Szapary PO, Strom BL, Hennessy S. Flory JH, et al. Among authors: szapary po. Diabetes Care. 2009 Apr;32(4):547-51. doi: 10.2337/dc08-1809. Epub 2009 Jan 8. Diabetes Care. 2009. PMID: 19131462 Free PMC article.

2

The triglyceride-high-density lipoprotein axis: an important target of therapy?

Szapary PO, Rader DJ. Szapary PO, et al. Am Heart J. 2004 Aug;148(2):211-21. doi: 10.1016/j.ahj.2004.03.037. Am Heart J. 2004. PMID: 15308990 Review.

3

Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol.

Szapary PO, Rader DJ. Szapary PO, et al. Curr Opin Pharmacol. 2001 Apr;1(2):113-20. doi: 10.1016/s1471-4892(01)00028-5. Curr Opin Pharmacol. 2001. PMID: 11714084 Review.

4

Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults.

Iqbal N, Cardillo S, Volger S, Bloedon LT, Anderson RA, Boston R, Szapary PO. Iqbal N, et al. Among authors: szapary po. Metab Syndr Relat Disord. 2009 Apr;7(2):143-50. doi: 10.1089/met.2008.0048. Metab Syndr Relat Disord. 2009. PMID: 19422140 Free PMC article. Clinical Trial.

5

Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation.

Rosas S, Szapary P, Rader DJ. Rosas S, et al. Cardiol Clin. 2003 Aug;21(3):377-92. doi: 10.1016/s0733-8651(03)00075-4. Cardiol Clin. 2003. PMID: 14621452 Review.

6

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.

Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirigliano MD, Rader DJ. Szapary PO, et al. JAMA. 2003 Aug 13;290(6):765-72. doi: 10.1001/jama.290.6.765. JAMA. 2003. PMID: 12915429 Clinical Trial.

7

Physical activity and its effects on lipids.

Szapary PO, Bloedon LT, Foster GD. Szapary PO, et al. Curr Cardiol Rep. 2003 Nov;5(6):488-92. doi: 10.1007/s11886-003-0112-2. Curr Cardiol Rep. 2003. PMID: 14558992 Review.

8

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.

Samaha FF, Szapary PO, Iqbal N, Williams MM, Bloedon LT, Kochar A, Wolfe ML, Rader DJ. Samaha FF, et al. Among authors: szapary po. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30. doi: 10.1161/01.ATV.0000200136.56716.30. Epub 2005 Dec 15. Arterioscler Thromb Vasc Biol. 2006. PMID: 16357312 Clinical Trial.

9

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Cuchel M, et al. Among authors: szapary po. N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189. N Engl J Med. 2007. PMID: 17215532 Free article. Clinical Trial.

10

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ. Szapary PO, et al. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page